Comorbidity and polypharmacy in Parkinson’s disease: comparative study with control group. Results from the COPPADIS Study Cohort | Fundación Degén
BLOG
VOLVER

Comorbidity and polypharmacy in Parkinson’s disease: comparative study with control group. Results from the COPPADIS Study Cohort